MedPath

Continuous Glucose Monitoring to Aid Weight Loss in Prediabetes

Not Applicable
Terminated
Conditions
PreDiabetes
Weight Loss
Interventions
Other: Dietitian
Device: CGM
Registration Number
NCT03844646
Lead Sponsor
Stanford University
Brief Summary

The primary objective of this study is to determine whether intermittent use of continuous glucose monitor will facilitate weight loss in individuals who are overweight/obese with prediabetes.

Detailed Description

Continuous glucose monitoring (CGM) has revolutionized the treatment of patients on intensive insulin therapy and its utility can also be harnessed to help individuals with prediabetes make healthful lifestyle changes. Successful weight loss requires adherence to lower calories, regular exercise, and self-monitoring. This proposal will test the hypothesis that intermittent CGM will facilitate all of these components for successful weight loss by functioning as a continuous self-monitor and guiding healthful food choices and physical activity.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Overweight/obese (BMI 25-40 kg/m2)
  • Prediabetes (fasting glucose 100-125 mg/dL and/or HbA1c 5.7-6.4%)
Exclusion Criteria
  • On glucose-lowering medications (e.g., metformin)
  • On weight-loss medications

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Dietitian onlyDietitianDietitian support only
CGM plus dietitianCGMIntermittent use of a continuous glucose monitor (CGM) plus dietitian support
CGM plus dietitianDietitianIntermittent use of a continuous glucose monitor (CGM) plus dietitian support
Primary Outcome Measures
NameTimeMethod
Amount of Weight Lost (kg)Baseline to end of study (3 months)

Weight lost during the study

Secondary Outcome Measures
NameTimeMethod
Number of Participants Reporting at Least 5 Days of Moderate Physical Activity of 30 Minutes or MoreBaseline to end of study (3 months)

Trial Locations

Locations (1)

Stanford

🇺🇸

Stanford, California, United States

© Copyright 2025. All Rights Reserved by MedPath